EKF Diagnostics (LON:EKF) Announces Earnings Results

EKF Diagnostics (LON:EKF) released its quarterly earnings data on Tuesday. The company reported GBX 0.54 earnings per share (EPS) for the quarter, Digital Look Earnings reports. EKF Diagnostics had a return on equity of 3.01% and a net margin of 4.12%.

EKF Diagnostics Trading Down 1.5%

EKF opened at GBX 25.60 on Tuesday. EKF Diagnostics has a twelve month low of GBX 22 and a twelve month high of GBX 31.70. The company has a 50-day simple moving average of GBX 25.44 and a 200 day simple moving average of GBX 25.51. The company has a quick ratio of 1.77, a current ratio of 4.16 and a debt-to-equity ratio of 2.01. The stock has a market capitalization of £109.61 million, a price-to-earnings ratio of 54.47 and a beta of 0.50.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.